# Effectiveness and Implementation of the Assessment of Burden of Chronic Conditions (ABCC)-Tool

Study · id `cardio:ct-nct04127383` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04127383](<https://clinicaltrials.gov/study/NCT04127383>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04127383

Browse, organ or system: Heart; Metabolism  
Browse, condition area: Heart failure; Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 237 participants.

## Technical summary

Registry record NCT04127383. Non-randomized; single masking; primary purpose treatment. Start 2019-11-01 (actual); primary completion 2022-11-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 237 participants (enrolled count; ClinicalTrials.gov record NCT04127383, source copy `cardio:ctgov-nct04127383-2023-03-16`, retrieved 2026-10-26)
- Started: 2019-11-01 (actual) (ClinicalTrials.gov record NCT04127383, source copy `cardio:ctgov-nct04127383-2023-03-16`, retrieved 2026-10-26)
- Primary completion: 2022-11-01 (actual) (ClinicalTrials.gov record NCT04127383, source copy `cardio:ctgov-nct04127383-2023-03-16`, retrieved 2026-10-26)
- Completion: 2022-11-01 (actual) (ClinicalTrials.gov record NCT04127383, source copy `cardio:ctgov-nct04127383-2023-03-16`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT04127383, source copy `cardio:ctgov-nct04127383-2023-03-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04127383-2023-03-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effectiveness and Implementation of the Assessment of Burden of Chronic Conditions (ABCC)-Tool
- Condition: Chronic Obstructive Pulmonary Disease
- Condition: Asthma
- Condition: Diabetes Mellitus, Type 2
- Condition: Heart Failure
- Intervention (Device): Assessment of Burden of Chronic Conditions (ABCC)-tool
- Lead sponsor: Maastricht University
- Lead sponsor class: OTHER
- Collaborator: Netherlands Instititute for Health Services Research
- Collaborator class: OTHER
- Collaborator: TNO
- Collaborator class: OTHER
- Collaborator: University of Twente
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effectiveness of the Assessment of Burden of Chronic Conditions (ABCC)-tool in patients with asthma, COPD, type 2 diabetes mellitus, and heart failure: A pragmatic clustered quasi-experimental study in the Netherlands (`cardio:pubmed-38738695`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 265f0de09ef82aa476e0515af76e8428a3d4ce6a947962173d9923a887968164
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
